25 XP   0   0   10

Generation Bio Co
Buy, Hold or Sell?

Let's analyse Generation Bio Co together

PenkeI guess you are interested in Generation Bio Co. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Generation Bio Co. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Generation Bio Co

I send you an email if I find something interesting about Generation Bio Co.

Quick analysis of Generation Bio Co (30 sec.)










What can you expect buying and holding a share of Generation Bio Co? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.06
Expected worth in 1 year
$1.86
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
$-1.19
Return On Investment
-29.3%

For what price can you sell your share?

Current Price per Share
$4.07
Expected price per share
$2.81 - $4.53
How sure are you?
50%

1. Valuation of Generation Bio Co (5 min.)




Live pricePrice per Share (EOD)

$4.07

Intrinsic Value Per Share

$-16.74 - $-19.58

Total Value Per Share

$-13.68 - $-16.52

2. Growth of Generation Bio Co (5 min.)




Is Generation Bio Co growing?

Current yearPrevious yearGrowGrow %
How rich?$203.1m$317.2m-$75.1m-31.0%

How much money is Generation Bio Co making?

Current yearPrevious yearGrowGrow %
Making money-$30.6m-$33m$2.3m7.8%
Net Profit Margin-1,517.5%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Generation Bio Co (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#257 / 1031

Most Revenue
#462 / 1031

Most Profit
#839 / 1031

Most Efficient
#845 / 1031

What can you expect buying and holding a share of Generation Bio Co? (5 min.)

Welcome investor! Generation Bio Co's management wants to use your money to grow the business. In return you get a share of Generation Bio Co.

What can you expect buying and holding a share of Generation Bio Co?

First you should know what it really means to hold a share of Generation Bio Co. And how you can make/lose money.

Speculation

The Price per Share of Generation Bio Co is $4.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Generation Bio Co.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Generation Bio Co, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.06. Based on the TTM, the Book Value Change Per Share is $-0.30 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Generation Bio Co.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.53-13.0%-0.48-11.7%-0.51-12.6%-0.46-11.4%-0.46-11.4%
Usd Book Value Change Per Share-0.43-10.6%-0.30-7.3%-0.37-9.2%0.184.4%0.184.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.43-10.6%-0.30-7.3%-0.37-9.2%0.184.4%0.184.4%
Usd Price Per Share1.65-3.81-5.79-12.13-12.13-
Price to Earnings Ratio-0.78--2.04--2.80--7.83--7.83-
Price-to-Total Gains Ratio-3.81--28.75--16.08--35.55--35.55-
Price to Book Ratio0.54-1.02-1.20-2.43-2.43-
Price-to-Total Gains Ratio-3.81--28.75--16.08--35.55--35.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.07
Number of shares245
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.300.18
Usd Total Gains Per Share-0.300.18
Gains per Quarter (245 shares)-73.1244.04
Gains per Year (245 shares)-292.50176.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-292-3020176166
20-585-5940352342
30-877-8860528518
40-1170-11780705694
50-1462-14700881870
60-1755-1762010571046
70-2047-2054012331222
80-2340-2346014091398
90-2632-2638015851574
100-2925-2930017611750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%3.014.00.017.6%3.014.00.017.6%3.014.00.017.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%3.014.00.017.6%3.014.00.017.6%3.014.00.017.6%

Fundamentals of Generation Bio Co

About Generation Bio Co

Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular delivery system for nucleic acids to avoid off-target clearance by the liver and spleen that enables ctLNPs to persist in systemic circulation, which allows for highly selective and potent ligand-driven targeting to specific tissues and cell types; and novel immune-quiet DNA (iqDNA) to enable long-lasting high levels of gene expression from non-integrating episomes and avoids innate immune sensors that have long prevented DNA from use in non-viral systems. It uses its platform for developing a portfolio of programs for treating cancer, autoimmune, hematologic disorders, prioritizing sickle cell, beta-thalassemia, and hemophilia A diseases, as well as for other tissues and cell types, including retina, skeletal muscle, and central nervous system. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-18 17:20:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Generation Bio Co.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Generation Bio Co earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Generation Bio Co to the Biotechnology industry mean.
  • A Net Profit Margin of -1,222.6% means that $-12.23 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Generation Bio Co:

  • The MRQ is -1,222.6%. The company is making a huge loss. -2
  • The TTM is -1,517.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,222.6%TTM-1,517.5%+294.9%
TTM-1,517.5%YOY--1,517.5%
TTM-1,517.5%5Y-357.1%-1,160.4%
5Y-357.1%10Y-357.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,222.6%-159.2%-1,063.4%
TTM-1,517.5%-202.3%-1,315.2%
YOY--263.0%+263.0%
5Y-357.1%-452.4%+95.3%
10Y-357.1%-589.0%+231.9%
1.1.2. Return on Assets

Shows how efficient Generation Bio Co is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Generation Bio Co to the Biotechnology industry mean.
  • -9.4% Return on Assets means that Generation Bio Co generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Generation Bio Co:

  • The MRQ is -9.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-7.7%-1.6%
TTM-7.7%YOY-8.0%+0.3%
TTM-7.7%5Y-9.4%+1.6%
5Y-9.4%10Y-9.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.4%-12.5%+3.1%
TTM-7.7%-12.2%+4.5%
YOY-8.0%-11.2%+3.2%
5Y-9.4%-13.3%+3.9%
10Y-9.4%-14.6%+5.2%
1.1.3. Return on Equity

Shows how efficient Generation Bio Co is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Generation Bio Co to the Biotechnology industry mean.
  • -17.3% Return on Equity means Generation Bio Co generated $-0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Generation Bio Co:

  • The MRQ is -17.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.3%TTM-12.9%-4.4%
TTM-12.9%YOY-10.4%-2.5%
TTM-12.9%5Y-9.4%-3.5%
5Y-9.4%10Y-9.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.3%-16.0%-1.3%
TTM-12.9%-15.8%+2.9%
YOY-10.4%-13.9%+3.5%
5Y-9.4%-18.2%+8.8%
10Y-9.4%-19.1%+9.7%

1.2. Operating Efficiency of Generation Bio Co.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Generation Bio Co is operating .

  • Measures how much profit Generation Bio Co makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Generation Bio Co to the Biotechnology industry mean.
  • An Operating Margin of -1,335.0% means the company generated $-13.35  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Generation Bio Co:

  • The MRQ is -1,335.0%. The company is operating very inefficient. -2
  • The TTM is -1,677.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,335.0%TTM-1,677.7%+342.7%
TTM-1,677.7%YOY--1,677.7%
TTM-1,677.7%5Y-394.8%-1,283.0%
5Y-394.8%10Y-394.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,335.0%-299.5%-1,035.5%
TTM-1,677.7%-208.5%-1,469.2%
YOY--280.2%+280.2%
5Y-394.8%-459.9%+65.1%
10Y-394.8%-596.9%+202.1%
1.2.2. Operating Ratio

Measures how efficient Generation Bio Co is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 15.03 means that the operating costs are $15.03 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Generation Bio Co:

  • The MRQ is 15.033. The company is inefficient in keeping operating costs low. -1
  • The TTM is 18.071. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ15.033TTM18.071-3.038
TTM18.071YOY-+18.071
TTM18.0715Y4.252+13.819
5Y4.25210Y4.2520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.0332.817+12.216
TTM18.0713.181+14.890
YOY-3.609-3.609
5Y4.2525.554-1.302
10Y4.2527.396-3.144

1.3. Liquidity of Generation Bio Co.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Generation Bio Co is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.83 means the company has $6.83 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Generation Bio Co:

  • The MRQ is 6.830. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.794. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.830TTM10.794-3.964
TTM10.794YOY18.788-7.995
TTM10.7945Y19.899-9.105
5Y19.89910Y19.8990.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8303.987+2.843
TTM10.7944.440+6.354
YOY18.7885.569+13.219
5Y19.8996.158+13.741
10Y19.8996.492+13.407
1.3.2. Quick Ratio

Measures if Generation Bio Co is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Generation Bio Co to the Biotechnology industry mean.
  • A Quick Ratio of 11.69 means the company can pay off $11.69 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Generation Bio Co:

  • The MRQ is 11.686. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 17.054. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.686TTM17.054-5.368
TTM17.054YOY25.677-8.624
TTM17.0545Y27.171-10.118
5Y27.17110Y27.1710.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.6863.653+8.033
TTM17.0544.158+12.896
YOY25.6775.515+20.162
5Y27.1716.012+21.159
10Y27.1716.206+20.965

1.4. Solvency of Generation Bio Co.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Generation Bio Co assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Generation Bio Co to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.46 means that Generation Bio Co assets are financed with 45.8% credit (debt) and the remaining percentage (100% - 45.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Generation Bio Co:

  • The MRQ is 0.458. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.394. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.458TTM0.394+0.064
TTM0.394YOY0.228+0.166
TTM0.3945Y0.400-0.006
5Y0.40010Y0.4000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4580.336+0.122
TTM0.3940.330+0.064
YOY0.2280.267-0.039
5Y0.4000.367+0.033
10Y0.4000.378+0.022
1.4.2. Debt to Equity Ratio

Measures if Generation Bio Co is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Generation Bio Co to the Biotechnology industry mean.
  • A Debt to Equity ratio of 84.5% means that company has $0.84 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Generation Bio Co:

  • The MRQ is 0.845. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.657. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.845TTM0.657+0.188
TTM0.657YOY0.296+0.361
TTM0.6575Y0.290+0.367
5Y0.29010Y0.2900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8450.376+0.469
TTM0.6570.398+0.259
YOY0.2960.334-0.038
5Y0.2900.431-0.141
10Y0.2900.476-0.186

2. Market Valuation of Generation Bio Co

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Generation Bio Co generates.

  • Above 15 is considered overpriced but always compare Generation Bio Co to the Biotechnology industry mean.
  • A PE ratio of -0.78 means the investor is paying $-0.78 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Generation Bio Co:

  • The EOD is -1.922. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.779. Based on the earnings, the company is expensive. -2
  • The TTM is -2.044. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.922MRQ-0.779-1.143
MRQ-0.779TTM-2.044+1.265
TTM-2.044YOY-2.799+0.754
TTM-2.0445Y-7.826+5.782
5Y-7.82610Y-7.8260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.922-2.697+0.775
MRQ-0.779-2.422+1.643
TTM-2.044-2.709+0.665
YOY-2.799-4.116+1.317
5Y-7.826-6.257-1.569
10Y-7.826-6.478-1.348
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Generation Bio Co:

  • The EOD is -2.288. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.928. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.499. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.288MRQ-0.928-1.361
MRQ-0.928TTM-0.499-0.429
TTM-0.499YOY-3.497+2.998
TTM-0.4995Y-8.616+8.117
5Y-8.61610Y-8.6160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.288-3.344+1.056
MRQ-0.928-2.939+2.011
TTM-0.499-3.486+2.987
YOY-3.497-5.592+2.095
5Y-8.616-8.464-0.152
10Y-8.616-8.872+0.256
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Generation Bio Co is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.54 means the investor is paying $0.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Generation Bio Co:

  • The EOD is 1.332. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.540. Based on the equity, the company is cheap. +2
  • The TTM is 1.022. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.332MRQ0.540+0.792
MRQ0.540TTM1.022-0.482
TTM1.022YOY1.198-0.176
TTM1.0225Y2.426-1.404
5Y2.42610Y2.4260.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.3322.198-0.866
MRQ0.5402.042-1.502
TTM1.0222.121-1.099
YOY1.1982.907-1.709
5Y2.4263.682-1.256
10Y2.4264.114-1.688
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Generation Bio Co.

3.1. Institutions holding Generation Bio Co

Institutions are holding 79.777% of the shares of Generation Bio Co.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31T. Rowe Price Associates, Inc.10.41890.00156926174-528529-7.0899
2023-12-31FMR Inc8.05150.00075352399-3080374-36.5286
2023-12-31Bellevue Group AG5.44110.0913361708000
2023-12-31BlackRock Inc4.76620.00013168415-185321-5.5258
2023-12-31Artal Group S A4.23330.1544281419100
2023-12-31Vanguard Group Inc3.83930.000125522512134679.1273
2023-12-31Bank of America Corp3.80260.000425278622020340398.0793
2023-09-30Partner Fund Management LP3.78240.44892514443-82993-3.1952
2023-12-31Goldman Sachs Group Inc3.48840.000323190121628543235.8604
2023-12-31EcoR1 Capital, LLC3.07910.0877204686700
2023-12-31Deutsche Bank AG1.85370.001123231612131166318.3125
2023-12-31Geode Capital Management, LLC1.62160.00021077963661936.5423
2023-12-31Morgan Stanley - Brokerage Accounts1.60060.00021064064561094111.5562
2023-12-31State Street Corporation1.38690.000192198782370.9015
2023-12-31UBS Group AG1.30480.0004867399469793118.1554
2023-12-31Millennium Management LLC1.13230.00057527457220742354.2565
2023-12-31Renaissance Technologies Corp1.0370.0018689400374600118.9962
2023-12-31Dimensional Fund Advisors, Inc.1.02760.0003683100-78319-10.2859
2023-12-31Charles Schwab Investment Management Inc0.57390.000238148048671.2923
2023-12-31Northern Trust Corp0.56120.000137308522230.5994
Total 63.00240.790241882233+3329011+7.9%

3.2. Funds holding Generation Bio Co

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31US Small-Cap Growth II Equity Comp6.07790.02694040381-12917-0.3187
2023-12-31T. Rowe Price New Horizons6.07790.02694040381-12917-0.3187
2023-09-30BB Biotech AG Ord5.42790.5587360828000
2024-01-31Fidelity Growth Compy Commingled Pl O2.90780.00511933041379732.0038
2024-01-31Fidelity Growth Company Fund2.78470.00641851176-17581-0.9408
2024-02-29Vanguard Total Stock Mkt Idx Inv2.33920.0003155502500
2023-12-31T. Rowe Price Health Sciences1.99020.01481323015-27491-2.0356
2024-02-29Xtrackers S&P 500 Swap ETF 1C1.85370.0342123231600
2024-02-29iShares Russell 2000 ETF1.64960.00441096602-179-0.0163
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.08020.001871807600
2024-01-31Fidelity Select Pharmaceuticals Port1.0760.144571527600
2023-12-31T. Rowe Price New Horizons Tr-Z0.96640.0245642427129172.0519
2024-01-31Fidelity Growth Company K60.75690.0056503195-12492-2.4224
2023-12-31Fidelity Small Cap Index0.68520.00345547858831.3085
2024-02-01iShares Russell 2000 Value ETF0.64310.0074274975400.1265
2024-01-31Fidelity Series Growth Company0.49510.0042329160-28100-7.8654
2024-01-31Fidelity Extended Market Index0.41120.001427333600
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.37840.001525151768002.7787
2023-12-31Bridgeway Ultra-Small Company0.36550.46262430002430000
2024-01-31JPM Thematics Genetic Thrps C2 Acc USD0.36510.060624268300
Total 38.3321.394425481862+195436+0.8%

3.3. Insider Transactions

Insiders are holding 14.468% of the shares of Generation Bio Co.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-02Antoinette PaoneSELL24451.62
2023-12-08Dannielle AppelhansBUY6371.82
2023-12-04Dannielle AppelhansBUY120001.5
2023-08-23Antoinette PaoneSELL31164.93
2023-07-03Phillip SamayoaSELL31165.29
2023-04-25Antoinette PaoneSELL29144.61

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Generation Bio Co compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.433-0.298-31%-0.373-14%0.180-341%0.180-341%
Book Value Per Share--3.0563.642-16%4.772-36%4.237-28%4.237-28%
Current Ratio--6.83010.794-37%18.788-64%19.899-66%19.899-66%
Debt To Asset Ratio--0.4580.394+16%0.228+101%0.400+15%0.400+15%
Debt To Equity Ratio--0.8450.657+29%0.296+185%0.290+191%0.290+191%
Dividend Per Share----0%-0%-0%-0%
Eps---0.529-0.476-10%-0.514-3%-0.464-12%-0.464-12%
Free Cash Flow Per Share---0.445-0.226-49%-0.418-6%-0.317-29%-0.317-29%
Free Cash Flow To Equity Per Share---0.443-0.091-79%-0.370-17%0.202-319%0.202-319%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---19.576--------
Intrinsic Value_10Y_min---16.739--------
Intrinsic Value_1Y_max---1.440--------
Intrinsic Value_1Y_min---1.414--------
Intrinsic Value_3Y_max---4.725--------
Intrinsic Value_3Y_min---4.503--------
Intrinsic Value_5Y_max---8.488--------
Intrinsic Value_5Y_min---7.844--------
Market Cap270561797.000+59%109687215.000253277751.000-57%384570023.500-71%806132597.941-86%806132597.941-86%
Net Profit Margin---12.226-15.175+24%--100%-3.571-71%-3.571-71%
Operating Margin---13.350-16.777+26%--100%-3.948-70%-3.948-70%
Operating Ratio--15.03318.071-17%-+100%4.252+254%4.252+254%
Pb Ratio1.332+59%0.5401.022-47%1.198-55%2.426-78%2.426-78%
Pe Ratio-1.922-147%-0.779-2.044+162%-2.799+259%-7.826+904%-7.826+904%
Price Per Share4.070+59%1.6503.810-57%5.785-71%12.126-86%12.126-86%
Price To Free Cash Flow Ratio-2.288-147%-0.928-0.499-46%-3.497+277%-8.616+829%-8.616+829%
Price To Total Gains Ratio-9.399-147%-3.810-28.753+655%-16.079+322%-35.554+833%-35.554+833%
Quick Ratio--11.68617.054-31%25.677-54%27.171-57%27.171-57%
Return On Assets---0.094-0.077-18%-0.080-14%-0.0940%-0.0940%
Return On Equity---0.173-0.129-25%-0.104-40%-0.094-46%-0.094-46%
Total Gains Per Share---0.433-0.298-31%-0.373-14%0.180-341%0.180-341%
Usd Book Value--203128000.000242117000.000-16%317257750.000-36%281675294.118-28%281675294.118-28%
Usd Book Value Change Per Share---0.433-0.298-31%-0.373-14%0.180-341%0.180-341%
Usd Book Value Per Share--3.0563.642-16%4.772-36%4.237-28%4.237-28%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.529-0.476-10%-0.514-3%-0.464-12%-0.464-12%
Usd Free Cash Flow---29558000.000-15035500.000-49%-27812250.000-6%-21046764.706-29%-21046764.706-29%
Usd Free Cash Flow Per Share---0.445-0.226-49%-0.418-6%-0.317-29%-0.317-29%
Usd Free Cash Flow To Equity Per Share---0.443-0.091-79%-0.370-17%0.202-319%0.202-319%
Usd Market Cap270561797.000+59%109687215.000253277751.000-57%384570023.500-71%806132597.941-86%806132597.941-86%
Usd Price Per Share4.070+59%1.6503.810-57%5.785-71%12.126-86%12.126-86%
Usd Profit---35186000.000-30627500.000-13%-33024000.000-6%-27667235.294-21%-27667235.294-21%
Usd Revenue--2878000.0001476000.000+95%-+100%347294.118+729%347294.118+729%
Usd Total Gains Per Share---0.433-0.298-31%-0.373-14%0.180-341%0.180-341%
 EOD+5 -3MRQTTM+8 -25YOY+4 -295Y+4 -2910Y+4 -29

4.2. Fundamental Score

Let's check the fundamental score of Generation Bio Co based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.922
Price to Book Ratio (EOD)Between0-11.332
Net Profit Margin (MRQ)Greater than0-12.226
Operating Margin (MRQ)Greater than0-13.350
Quick Ratio (MRQ)Greater than111.686
Current Ratio (MRQ)Greater than16.830
Debt to Asset Ratio (MRQ)Less than10.458
Debt to Equity Ratio (MRQ)Less than10.845
Return on Equity (MRQ)Greater than0.15-0.173
Return on Assets (MRQ)Greater than0.05-0.094
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Generation Bio Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.032
Ma 20Greater thanMa 503.140
Ma 50Greater thanMa 1002.448
Ma 100Greater thanMa 2002.013
OpenGreater thanClose3.720
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  -11,464-1,825-13,289-51,049-64,33850,692-13,64645,09431,448



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets374,758
Total Liabilities171,630
Total Stockholder Equity203,128
 As reported
Total Liabilities 171,630
Total Stockholder Equity+ 203,128
Total Assets = 374,758

Assets

Total Assets374,758
Total Current Assets272,618
Long-term Assets102,140
Total Current Assets
Cash And Cash Equivalents 66,446
Short-term Investments 197,918
Net Receivables 4,148
Inventory 3,816
Other Current Assets 290
Total Current Assets  (as reported)272,618
Total Current Assets  (calculated)272,618
+/-0
Long-term Assets
Property Plant Equipment 95,651
Long-term Assets Other 698
Long-term Assets  (as reported)102,140
Long-term Assets  (calculated)96,349
+/- 5,791

Liabilities & Shareholders' Equity

Total Current Liabilities39,914
Long-term Liabilities131,716
Total Stockholder Equity203,128
Total Current Liabilities
Short-term Debt 8,120
Accounts payable 2,346
Other Current Liabilities 16,529
Total Current Liabilities  (as reported)39,914
Total Current Liabilities  (calculated)26,995
+/- 12,919
Long-term Liabilities
Capital Lease Obligations 97,894
Long-term Liabilities  (as reported)131,716
Long-term Liabilities  (calculated)97,894
+/- 33,822
Total Stockholder Equity
Common Stock7
Retained Earnings -571,377
Accumulated Other Comprehensive Income 274
Other Stockholders Equity 774,224
Total Stockholder Equity (as reported)203,128
Total Stockholder Equity (calculated)203,128
+/-0
Other
Capital Stock7
Cash and Short Term Investments 264,364
Common Stock Shares Outstanding 64,484
Current Deferred Revenue12,919
Liabilities and Stockholders Equity 374,758
Net Debt 31,448
Net Invested Capital 203,128
Net Working Capital 232,704
Property Plant and Equipment Gross 115,346
Short Long Term Debt Total 97,894



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
42,140
132,636
331,202
310,922
294,155
514,081
490,792
464,033
476,771
444,026
418,994
402,799
376,264
431,417
404,883
381,492
374,758
374,758381,492404,883431,417376,264402,799418,994444,026476,771464,033490,792514,081294,155310,922331,202132,63642,140000
   > Total Current Assets 
0
0
0
18,156
107,292
306,177
285,813
267,735
455,785
432,741
403,270
379,186
341,563
321,131
310,558
287,016
344,733
320,623
297,809
272,618
272,618297,809320,623344,733287,016310,558321,131341,563379,186403,270432,741455,785267,735285,813306,177107,29218,156000
       Cash And Cash Equivalents 
0
0
0
15,076
104,473
171,691
58,605
62,889
366,304
392,072
388,347
375,145
336,978
158,265
134,487
93,171
95,650
144,970
93,360
66,446
66,44693,360144,97095,65093,171134,487158,265336,978375,145388,347392,072366,30462,88958,605171,691104,47315,076000
       Short-term Investments 
0
0
0
0
0
129,395
221,761
199,438
84,779
33,121
10,016
199,438
0
153,939
166,682
185,920
192,999
169,173
197,665
197,918
197,918197,665169,173192,999185,920166,682153,9390199,43810,01633,12184,779199,438221,761129,39500000
       Net Receivables 
0
0
0
448
32
0
0
252
0
0
0
403
5,582
1,778
395
395
49,314
340
660
4,148
4,14866034049,3143953951,7785,5824030002520032448000
       Other Current Assets 
0
0
0
2,632
2,787
5,091
5,447
5,408
4,702
7,548
4,907
4,041
4,585
7,149
8,994
7,530
56,084
6,480
6,124
290
2906,1246,48056,0847,5308,9947,1494,5854,0414,9077,5484,7025,4085,4475,0912,7872,632000
   > Long-term Assets 
0
0
0
23,984
25,344
25,025
25,109
26,420
58,296
58,051
60,763
97,585
102,463
97,863
92,241
89,248
86,684
84,260
83,683
102,140
102,14083,68384,26086,68489,24892,24197,863102,46397,58560,76358,05158,29626,42025,10925,02525,34423,984000
       Property Plant Equipment 
0
0
0
21,845
22,617
22,822
22,888
23,781
55,908
55,597
54,214
91,029
90,728
87,843
84,561
81,423
79,975
77,802
76,790
95,651
95,65176,79077,80279,97581,42384,56187,84390,72891,02954,21455,59755,90823,78122,88822,82222,61721,845000
       Other Assets 
0
0
0
0
2,727
2,203
2,221
2,639
2,388
2,454
6,549
6,556
11,735
10,020
7,680
7,825
0
6,458
0
0
006,45807,8257,68010,02011,7356,5566,5492,4542,3882,6392,2212,2032,7270000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
472
0
0
0
0
0
0
0
0
0
0000000004720000000000
> Total Liabilities 
0
0
0
140,732
22,862
27,049
24,383
26,142
55,345
57,390
56,823
95,025
91,111
94,120
94,050
93,771
152,278
150,596
149,578
171,630
171,630149,578150,596152,27893,77194,05094,12091,11195,02556,82357,39055,34526,14224,38327,04922,862140,732000
   > Total Current Liabilities 
0
0
0
9,158
7,093
11,536
9,163
11,220
10,794
13,931
14,506
18,808
15,254
16,185
17,318
19,150
22,737
26,479
32,819
39,914
39,91432,81926,47922,73719,15017,31816,18515,25418,80814,50613,93110,79411,2209,16311,5367,0939,158000
       Short-term Debt 
0
0
0
0
0
0
0
0
4,217
4,287
4,359
4,608
4,780
6,119
6,630
7,086
7,905
8,135
8,721
8,120
8,1208,7218,1357,9057,0866,6306,1194,7804,6084,3594,2874,21700000000
       Accounts payable 
0
0
0
2,251
464
2,624
418
267
296
589
520
2,023
1,547
1,087
1,693
662
1,504
2,328
2,650
2,346
2,3462,6502,3281,5046621,6931,0871,5472,0235205892962674182,6244642,251000
       Other Current Liabilities 
0
0
0
6,907
6,629
8,912
8,745
10,953
639
1,218
740
676
8,927
8,979
8,995
11,402
7,647
7,751
9,474
16,529
16,5299,4747,7517,64711,4028,9958,9798,9276767401,21863910,9538,7458,9126,6296,907000
   > Long-term Liabilities 
0
0
0
131,574
15,769
15,513
15,220
14,922
44,551
43,459
42,317
76,217
75,857
77,935
76,732
74,621
129,541
124,117
116,759
131,716
131,716116,759124,117129,54174,62176,73277,93575,85776,21742,31743,45944,55114,92215,22015,51315,769131,574000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
472
0
0
0
0
0
0
0
0
0
0000000004720000000000
       Other Liabilities 
0
0
0
0
15,769
15,513
15,220
14,922
0
0
0
0
0
0
0
0
0
51,620
0
0
0051,62000000000014,92215,22015,51315,7690000
       Deferred Long Term Liability 
0
0
0
0
658
0
0
336
0
0
472
461
461
456
434
434
0
433
0
0
00433043443445646146147200336006580000
> Total Stockholder Equity
0
0
0
-98,592
109,774
304,153
286,539
268,013
458,736
433,402
407,210
381,746
352,915
324,874
308,749
282,493
279,139
254,287
231,914
203,128
203,128231,914254,287279,139282,493308,749324,874352,915381,746407,210433,402458,736268,013286,539304,153109,774-98,592000
   Common Stock
0
0
0
1
3
5
5
5
6
6
6
6
6
6
6
6
7
7
7
7
77776666666655531000
   Retained Earnings Total Equity00-507,925-476,859-444,765-412,360-381,054-343,125-308,126-277,183-245,328-214,537-188,9750000000
   Accumulated Other Comprehensive Income 
0
0
0
-2,230
-2,907
-4
26
9
10
4
0
0
0
-339
-302
-83
34
-23
-4
274
274-4-2334-83-302-339000410926-4-2,907-2,230000
   Capital Surplus 
0
0
0
0
11,517
0
0
456,974
673,257
678,720
684,387
689,866
696,034
706,261
721,405
727,335
755,957
762,228
0
0
00762,228755,957727,335721,405706,261696,034689,866684,387678,720673,257456,9740011,5170000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
9,859
235,940
116,850
140,335
162,819
673,257
678,720
684,387
689,866
696,034
706,261
721,405
727,335
755,957
762,228
768,102
774,224
774,224768,102762,228755,957727,335721,405706,261696,034689,866684,387678,720673,257162,819140,335116,850235,9409,859000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,904
Cost of Revenue-5,263
Gross Profit641641
 
Operating Income (+$)
Gross Profit641
Operating Expense-144,467
Operating Income-138,563-143,826
 
Operating Expense (+$)
Research Development93,617
Selling General Administrative50,850
Selling And Marketing Expenses0
Operating Expense144,467144,467
 
Net Interest Income (+$)
Interest Income11,951
Interest Expense-11,951
Other Finance Cost-11,951
Net Interest Income11,951
 
Pretax Income (+$)
Operating Income-138,563
Net Interest Income11,951
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-126,612-150,514
EBIT - interestExpense = -150,514
-126,612
-114,661
Interest Expense11,951
Earnings Before Interest and Taxes (EBIT)-138,563-114,661
Earnings Before Interest and Taxes (EBITDA)-133,300
 
After tax Income (+$)
Income Before Tax-126,612
Tax Provision-0
Net Income From Continuing Ops-126,612-126,612
Net Income-126,612
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses144,467
Total Other Income/Expenses Net11,951-11,951
 

Technical Analysis of Generation Bio Co
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Generation Bio Co. The general trend of Generation Bio Co is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Generation Bio Co's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Generation Bio Co.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 4.07 < 4.22 < 4.53.

The bearish price targets are: 3.705 > 3.59 > 2.81.

Tweet this
Generation Bio Co Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Generation Bio Co. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Generation Bio Co Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Generation Bio Co. The current macd is 0.33211725.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Generation Bio Co price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Generation Bio Co. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Generation Bio Co price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Generation Bio Co Daily Moving Average Convergence/Divergence (MACD) ChartGeneration Bio Co Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Generation Bio Co. The current adx is 50.01.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Generation Bio Co shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Generation Bio Co Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Generation Bio Co. The current sar is 2.88462531.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Generation Bio Co Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Generation Bio Co. The current rsi is 76.03. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Generation Bio Co Daily Relative Strength Index (RSI) ChartGeneration Bio Co Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Generation Bio Co. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 5/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Generation Bio Co price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Generation Bio Co Daily Stochastic Oscillator ChartGeneration Bio Co Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Generation Bio Co. The current cci is 239.15.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Generation Bio Co Daily Commodity Channel Index (CCI) ChartGeneration Bio Co Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Generation Bio Co. The current cmo is 59.38.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Generation Bio Co Daily Chande Momentum Oscillator (CMO) ChartGeneration Bio Co Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Generation Bio Co. The current willr is -14.86486486.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Generation Bio Co Daily Williams %R ChartGeneration Bio Co Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Generation Bio Co.

Generation Bio Co Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Generation Bio Co. The current atr is 0.28614851.

Generation Bio Co Daily Average True Range (ATR) ChartGeneration Bio Co Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Generation Bio Co. The current obv is 23,286,201.

Generation Bio Co Daily On-Balance Volume (OBV) ChartGeneration Bio Co Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Generation Bio Co. The current mfi is 52.03.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Generation Bio Co Daily Money Flow Index (MFI) ChartGeneration Bio Co Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Generation Bio Co.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Generation Bio Co Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Generation Bio Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.032
Ma 20Greater thanMa 503.140
Ma 50Greater thanMa 1002.448
Ma 100Greater thanMa 2002.013
OpenGreater thanClose3.720
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Generation Bio Co with someone you think should read this too:
  • Are you bullish or bearish on Generation Bio Co? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Generation Bio Co? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Generation Bio Co

I send you an email if I find something interesting about Generation Bio Co.


Comments

How you think about this?

Leave a comment

Stay informed about Generation Bio Co.

Receive notifications about Generation Bio Co in your mailbox!